Cargando…

Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review

The management of digital ulcers in systemic sclerosis is difficult. While the 2017 European League Against Rheumatism (EULAR) guidelines clearly defined the use of systemic therapies for digital ulcers, little is known about the efficacy of locoregional treatments. The aim of this review is to syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	COSTEDOAT, Ingrid, MASSON, Maeva, BARNETCHE, Thomas, DUFFAU, Pierre, LAZARO, Estibaliz, RICHEZ, Christophe, SENESCHAL, Julien, TRUCHETET, Marie-Elise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380280/ https://www.ncbi.nlm.nih.gov/pubmed/34043013 http://dx.doi.org/10.2340/00015555-3839

Ejemplares similares

Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
por: Gensous, Noémie, et al.
Publicado: (2017)

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
por: Laurent, Paoline, et al.
Publicado: (2018)

Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis
por: Leleu, Damien, et al.
Publicado: (2020)

T Follicular Helper Cells in Autoimmune Disorders
por: Gensous, Noémie, et al.
Publicado: (2018)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Implications du COVID-19 pour la prise en charge des rhumatismes inflammatoires chroniques()
por: Richez, Christophe, et al.
Publicado: (2020)

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis
por: Laurent, Paôline, et al.
Publicado: (2021)

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy
por: Vercruysse, François, et al.
Publicado: (2019)

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
por: Truchetet, Marie-Elise, et al.
Publicado: (2016)

Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study
por: Bazin, Thomas, et al.
Publicado: (2018)

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
por: Bertrand, Anne, et al.
Publicado: (2015)

Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment
por: Avouac, Jérôme, et al.
Publicado: (2023)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

La prophylaxie pré-exposition par tixagévimab/cilgavimab est efficace pour limiter le risque de contamination et la sévérité de la COVID-19 des patients atteints de maladies auto-immunes ou inflammatoires insuffisamment répondeurs à la vaccination
por: Thomas, M., et al.
Publicado: (2022)

Current Concepts on the Pathogenesis of Systemic Sclerosis
por: Truchetet, Marie Elise, et al.
Publicado: (2021)

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
por: Ladouceur, Alexandra, et al.
Publicado: (2023)

Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis
por: Martin, Mickaël, et al.
Publicado: (2019)

Dynamics of digital ulcers in systemic sclerosis
por: Bobeică, Carmen, et al.
Publicado: (2020)

Dynamics of digital ulcers in systemic sclerosis
por: Bobeică, Carmen, et al.
Publicado: (2020)

Registry Evaluation of Digital Ulcers in Systemic Sclerosis
por: Galluccio, Felice, et al.
Publicado: (2010)

Optimal management of digital ulcers in systemic sclerosis
por: Abraham, Shawn, et al.
Publicado: (2015)

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease
por: Truchetet, Marie-Elise, et al.
Publicado: (2011)

The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE (−/−) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
por: Richez, Christophe, et al.
Publicado: (2013)

Role of Traditional Risk Factors and Antiretroviral Drugs in the Incidence of Chronic Kidney Disease, ANRS CO3 Aquitaine Cohort, France, 2004–2012
por: Morlat, Philippe, et al.
Publicado: (2013)

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
por: Djabarouti, Sarah, et al.
Publicado: (2011)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
por: Djabarouti, Sarah, et al.
Publicado: (2010)

Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000–2012
por: Collin, Amandine, et al.
Publicado: (2016)

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
por: Ross, Laura, et al.
Publicado: (2023)

Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts
por: Brembilla, Nicolò Costantino, et al.
Publicado: (2013)

Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study
por: Dousset, Léa, et al.
Publicado: (2021)

Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study
por: DUPONT, Aurore, et al.
Publicado: (2023)

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
por: De La Fuente, Fanny, et al.
Publicado: (2022)

A Method for Isolating and Culturing Skin Cells: Application to Endothelial Cells, Fibroblasts, Keratinocytes, and Melanocytes From Punch Biopsies in Systemic Sclerosis Skin
por: Henrot, Pauline, et al.
Publicado: (2020)

Prevention of infection in asplenic adult patients by general practitioners in France between 2013 and 2016: Care for the asplenic patient in general practice
por: Quéffélec, Charlotte, et al.
Publicado: (2020)

Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers
por: Souk, Jin-Woo, et al.
Publicado: (2019)

Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers
por: Starnoni, Marta, et al.
Publicado: (2021)

Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives
por: Sagonas, Ioannis, et al.
Publicado: (2023)

Use of eHealth by Patients With Rheumatoid Arthritis: Observational, Cross-sectional, Multicenter Study
por: Magnol, Marion, et al.
Publicado: (2021)

Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort
por: Allanore, Yannick, et al.
Publicado: (2016)

Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
por: Kostine, Marie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oukm4ic3i0mv72eijjl3r29dm7